• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用液基细胞学进行甲状腺病变鉴别诊断的免疫细胞化学分析。

Immunocytochemical analysis for differential diagnosis of thyroid lesions using liquid-based cytology.

作者信息

Hashimoto Katsunori, Morimoto Ayumi, Kato Makoto, Tominaga Yoshihiro, Maeda Nagako, Tsuzuki Toyonori, Yokoi Toyoharu, Nagasaka Tetsuro

机构信息

Department of Medical Technology, Nagoya University School of Health Sciences, Nagoya, Japan.

出版信息

Nagoya J Med Sci. 2011 Feb;73(1-2):15-24.

PMID:21614933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11254360/
Abstract

Recently, liquid-based cytology (LBC) has been widely applied to various samples in diagnostic cytology and its usefulness has been reported. In this study, we investigated thyroid cytology that applied LBC and immunocytochemistry to achieve more objective diagnosis and greater diagnostic accuracy. This study included 125 cases (57 papillary carcinomas (PCs), 22 follicular tumors, 43 adenomatous goiters and 3 with Basedow's disease). After preparing the LBC slide, immunocytochemical staining was performed on each slide with six antibodies (HBME-1, cytokeratin 19 (CK19), high molecular weight cytokeratin (34JE12), galectin-3, CD15 and CA 19-9). All antibodies presented immunopositivity frequently in PCs, but only a few or some of them were positive in other cases. These antibodies were considered positive markers for PCs, and the most reliable marker was 34betaE12; its sensitivity, specificity and diagnostic accuracy were 82.5%, 100% and 92.0%, respectively. Relations of immunocytochemical profiles against these markers were assessed using panel 34betaE12, GAL-3 and CK19. More than or equal to two of these markers showed co-positive in 53 of 57 PCs, and negative for all markers was observed in only one case. In the other (non PC) cases, the former was 0 of 58 and the latter was 40 cases. In this panel, the sensitivity, specificity and diagnostic accuracy were 93.0%, 100% and 96.8%, respectively. All of these values were higher than or equal to single values of 34betaE12. We concluded that the panel in this study is useful for more objective and accurate diagnosis of thyroid cytology.

摘要

近年来,液基细胞学(LBC)已广泛应用于诊断细胞学的各种样本,其效用也已有报道。在本研究中,我们探讨了应用LBC和免疫细胞化学的甲状腺细胞学,以实现更客观的诊断和更高的诊断准确性。本研究纳入了125例病例(57例乳头状癌(PC)、22例滤泡性肿瘤、43例腺瘤性甲状腺肿和3例伴有巴塞多氏病)。制备LBC玻片后,用六种抗体(HBME-1、细胞角蛋白19(CK19)、高分子量细胞角蛋白(34JE12)、半乳糖凝集素-3、CD15和CA 19-9)对每张玻片进行免疫细胞化学染色。所有抗体在PC中均频繁呈现免疫阳性,但在其他病例中只有少数或部分呈阳性。这些抗体被认为是PC的阳性标志物,最可靠的标志物是34βE12;其敏感性、特异性和诊断准确性分别为82.5%、100%和92.0%。使用34βE12、GAL-3和CK19组合评估针对这些标志物的免疫细胞化学图谱关系。在57例PC中,53例有两种或两种以上这些标志物呈共同阳性,仅1例所有标志物均为阴性。在其他(非PC)病例中,前者在58例中为0例,后者为40例。在该组合中,敏感性、特异性和诊断准确性分别为93.0%、100%和96.8%。所有这些值均高于或等于34βE12的单个值。我们得出结论,本研究中的组合有助于更客观准确地诊断甲状腺细胞学。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd8/11254360/a7f407947fd7/2186-3326-73-0015-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd8/11254360/f63fe034646c/2186-3326-73-0015-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd8/11254360/a7f407947fd7/2186-3326-73-0015-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd8/11254360/f63fe034646c/2186-3326-73-0015-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd8/11254360/a7f407947fd7/2186-3326-73-0015-g002.jpg

相似文献

1
Immunocytochemical analysis for differential diagnosis of thyroid lesions using liquid-based cytology.使用液基细胞学进行甲状腺病变鉴别诊断的免疫细胞化学分析。
Nagoya J Med Sci. 2011 Feb;73(1-2):15-24.
2
Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.CD56和E-钙黏蛋白表达在甲状腺乳头状癌与疑似甲状腺滤泡样病变鉴别诊断中的作用:E-钙黏蛋白的预后重要性
Int J Clin Exp Pathol. 2015 Apr 1;8(4):3670-80. eCollection 2015.
3
Immunohistochemical diagnosis of papillary thyroid carcinoma.甲状腺乳头状癌的免疫组织化学诊断
Mod Pathol. 2001 Apr;14(4):338-42. doi: 10.1038/modpathol.3880312.
4
Improvement of the cytological diagnostic accuracy of follicular thyroid lesions by the use of the Ki-67 proliferative index in addition to cytokeratin-19 and HBME-1 immunomarkers: a study of 61 cases of liquid-based FNA cytology with histological controls.除细胞角蛋白-19和HBME-1免疫标志物外,使用Ki-67增殖指数提高甲状腺滤泡性病变的细胞学诊断准确性:一项对61例液基细针穿刺活检细胞学病例并结合组织学对照的研究
Cytopathology. 2014 Jun;25(3):160-9. doi: 10.1111/cyt.12128. Epub 2014 Jan 27.
5
Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-1.通过细胞角蛋白19、半乳糖凝集素-3和HBME-1免疫组化染色鉴别甲状腺乳头状增生和甲状腺乳头状癌。
Endocr Pathol. 2003 Spring;14(1):55-60. doi: 10.1385/ep:14:1:55.
6
The Role of CD56 in Thyroid Fine Needle Aspiration Cytology: A Pilot Study Performed on Liquid Based Cytology.CD56在甲状腺细针穿刺细胞学中的作用:一项基于液基细胞学的初步研究
PLoS One. 2015 Jul 17;10(7):e0132939. doi: 10.1371/journal.pone.0132939. eCollection 2015.
7
Universal markers of thyroid malignancies: galectin-3, HBME-1, and cytokeratin-19.甲状腺恶性肿瘤的通用标志物:半乳糖凝集素-3、HBME-1 和细胞角蛋白 19。
Endocr Pathol. 2010 Jun;21(2):80-9. doi: 10.1007/s12022-010-9114-y.
8
Differential diagnostic significance of HBME-1, CK19 and S100 in various thyroid lesions.HBME-1、CK19和S100在各种甲状腺病变中的鉴别诊断意义。
Malays J Pathol. 2017 Apr;39(1):55-67.
9
[Usefulness of CK19, HBME-1 and galectin-3 expressions in differential diagnosis of thyroid papillary microcarcinoma from benign lesions].[CK19、HBME-1和半乳糖凝集素-3表达在甲状腺微小乳头状癌与良性病变鉴别诊断中的应用价值]
Zhonghua Zhong Liu Za Zhi. 2011 Aug;33(8):599-604.
10
Expression of cytokeratin 19, HBME-1 and galectin-3 in neoplastic and nonneoplastic thyroid lesions.细胞角蛋白19、HBME-1和半乳糖凝集素-3在肿瘤性和非肿瘤性甲状腺病变中的表达
Pol J Pathol. 2012 Mar;63(1):58-64.

引用本文的文献

1
Fine-Needle Aspiration Cytology for Parotid Tumors.腮腺肿瘤的细针穿刺抽吸细胞学检查
Life (Basel). 2022 Nov 15;12(11):1897. doi: 10.3390/life12111897.
2
Systematic Review and Meta-Analysis to Identify the Immunocytochemical Markers Effective in Delineating Benign from Malignant Thyroid Lesions in FNAC Samples.系统评价和荟萃分析以确定在细针穿刺抽吸活检样本中用于区分良恶性甲状腺病变的免疫细胞化学标志物。
Endocr Pathol. 2022 Jun;33(2):243-256. doi: 10.1007/s12022-022-09721-5. Epub 2022 May 21.
3
Current methodologies for molecular screening of thyroid nodules.

本文引用的文献

1
Differential expression of galectin-3, CK19, HBME1, and Ret oncoprotein in the diagnosis of thyroid neoplasms by fine needle aspiration biopsy.通过细针穿刺活检检测半乳糖凝集素-3、细胞角蛋白19、人甲状腺转录因子-1及Ret原癌蛋白的差异表达在甲状腺肿瘤诊断中的应用
Cytojournal. 2009 Sep 18;6:18. doi: 10.4103/1742-6413.55894.
2
HBME-1 and CK19 are highly discriminatory in the cytological diagnosis of papillary thyroid carcinoma.HBME-1和CK19在甲状腺乳头状癌的细胞学诊断中具有高度鉴别性。
Diagn Cytopathol. 2008 Aug;36(8):550-6. doi: 10.1002/dc.20841.
3
Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27(kip1) in the differential diagnosis of thyroid nodules.
甲状腺结节分子筛查的当前方法。
Gland Surg. 2018 Aug;7(Suppl 1):S1-S7. doi: 10.21037/gs.2017.08.04.
4
Diagnostic value of liquid-based cytology with fine needle aspiration specimens for cervical lymphadenopathy.液基细胞学联合细针穿刺标本对颈部淋巴结病的诊断价值
Diagn Cytopathol. 2016 Mar;44(3):169-76. doi: 10.1002/dc.23402. Epub 2016 Jan 9.
5
Hypoxia Up-Regulates Galectin-3 in Mammary Tumor Progression and Metastasis.缺氧在乳腺肿瘤进展和转移过程中上调半乳糖凝集素-3
PLoS One. 2015 Jul 29;10(7):e0134458. doi: 10.1371/journal.pone.0134458. eCollection 2015.
半乳糖凝集素-3、人鼠杂交瘤单克隆抗体-1、细胞角蛋白19、高分子量细胞角蛋白、细胞周期蛋白D1和p27(kip1)在甲状腺结节鉴别诊断中的诊断价值
J Korean Med Sci. 2007 Aug;22(4):621-8. doi: 10.3346/jkms.2007.22.4.621.
4
Direct-to-vial comparison of a new liquid-based cytology system, liqui-PREP versus the conventional pap smear.一种新型液基细胞学系统liqui-PREP与传统巴氏涂片的直接样本瓶比较。
Diagn Cytopathol. 2007 Aug;35(8):488-92. doi: 10.1002/dc.20665.
5
Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors.半乳糖凝集素-3、纤连蛋白-1、CITED-1、HBME1和细胞角蛋白-19免疫组化对甲状腺肿瘤的鉴别诊断有用。
Mod Pathol. 2005 Jan;18(1):48-57. doi: 10.1038/modpathol.3800235.
6
Diagnostic utility of galectin-3 and CD26/DPPIV as preoperative diagnostic markers for thyroid nodules.半乳糖凝集素-3和CD26/二肽基肽酶IV作为甲状腺结节术前诊断标志物的诊断效用
Diagn Cytopathol. 2002 Jun;26(6):366-72. doi: 10.1002/dc.10111.
7
Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer.ret/PTC基因重排分析可优化甲状腺癌的细针穿刺诊断。
J Clin Endocrinol Metab. 2001 May;86(5):2187-90. doi: 10.1210/jcem.86.5.7504.
8
Immunohistochemical diagnosis of papillary thyroid carcinoma.甲状腺乳头状癌的免疫组织化学诊断
Mod Pathol. 2001 Apr;14(4):338-42. doi: 10.1038/modpathol.3880312.
9
Fine-needle aspiration biopsy of papillary thyroid carcinoma: diagnostic utility of cytokeratin 19 immunostaining.甲状腺乳头状癌的细针穿刺活检:细胞角蛋白19免疫染色的诊断效用
Cancer. 2000 Oct 25;90(5):307-11.
10
Immunocytochemical evaluation of HBME-1, CA 19-9, and CD-15 (Leu-M1) in fine-needle aspirates of thyroid nodules.甲状腺结节细针穿刺抽吸物中HBME-1、CA 19-9和CD-15(Leu-M1)的免疫细胞化学评估。
Diagn Cytopathol. 1998 Feb;18(2):93-7. doi: 10.1002/(sici)1097-0339(199802)18:2<93::aid-dc3>3.0.co;2-u.